Panel 4: Health Policy Academy Deep Dive: Artificial Intelligence in Health Care

March 24, 2026

2:15 pm-

3:15 pm

This panel will provide an overview of how artificial intelligence is being used in health care and how the legislative and regulatory landscape has evolved over the past year. Building on the Alliance’s 2024 Signature Series on AI, the session will examine key developments since 2024, including actions by Congress, the Administration, federal agencies, and states.

The discussion will highlight why health care AI presents distinct policy considerations compared to other sectors and surface the key questions congressional staff are likely to encounter in the year ahead.

Speakers:

Moderator: Aubrey Wilson, Director of Government Innovation & Global Initiatives, POPVOX Foundation
Laura Adams, M.S., Senior Advisor, National Academy of Medicine (NAM)
Jodi Daniel, J.D., MPH, Partner, Wilson Sonsini Goodrich & Rosati

Speakers

Aubrey Wilson

Director of Government Innovation & Global Initiatives, POPVOX Foundation

Aubrey Wilson is Director of Government Innovation & Global Initiatives at the nonpartisan, nonprofit POPVOX Foundation where she supports Congress and international legislatures by creating training and resources (many focused on the use of AI). She served as former Deputy Staff Director for the Committee on House Administration (CHA) in the 118th Congress, overseeing institutional modernization including the inaugural session of CHA’s bipartisan Subcommittee on Modernization. Prior Aubrey served as Director of Oversight and Modernization for CHA during the 117th Congress. She is a former House legislative assistant and member of the R Street Institute Governance Policy and federal affairs team. She is host of POPVOX’s Gavel In podcast and managing director of the Digital Parliaments Project.

Laura Adams, M.S.

Senior Advisor, National Academy of Medicine (NAM)

Laura Adams, Senior Advisor at the National Academy of Medicine (NAM), leads NAM’s Artificial Intelligence Code of Conduct and the NAM Patient Safety in the Era of AI national initiatives. Laura chairs the Global Opportunities Group for The Centre of Excellence for AI Regulatory Science and Innovation in the UK, and she is a strategic advisor for Inflammatix, a Burlingame, CA-based biotech company specializing in host immune response diagnostics. Her expertise is in AI governance, digital health, and human-centered care. Laura is a member of the international Expert Panel on Health AI for the Organization of Economic Co-operation and Development (OECD); the Bipartisan Policy Center’s Health Care AI Advisory Panel; and the Consumer Technology Association’s Health AI Planning Council. She is recognized as a strategic leader of large scale multisectoral initiatives with a deep experience in and understanding of the complex U.S. health care industry, including how the components function and interact. Laura was among the first to bring the science of clinical quality improvement to the Middle East, in conjunction with Donald Berwick, MD and the Harvard Institute for Social and Economic Policy in the Middle East. Prior to her work at the NAM, Laura was founding President and CEO of the Rhode Island Quality Institute (RIQI), a living laboratory for advancing health information exchange. Under her leadership, RIQI won the National Council for Community Behavioral Health Excellence Award for Impact on the opioid crisis. Laura has delivered keynotes in nearly every state in the union and in 14 countries worldwide.

Jodi Daniel, J.D., MPH

Partner, Wilson Sonsini Goodrich & Rosati

Jodi Daniel is a partner at Wilson Sonsini where she provides strategic, legal, and policy advice to healthcare providers and health plans that are bringing innovation into practice, and to health technology clients navigating the dynamic health regulatory environment. Jodi is a leader in digital health and health data policy. She was the founding director of the Office of Policy in the Office of the National Coordinator for Health IT (ONC) at HHS, where she led the agency’s federal advisory committees and established national health IT policy on privacy, security, consumer e-health, telehealth, and safety and oversight. Jodi developed ONC’s regulatory capacity, led the adoption of health IT standards and certification regulations, and advised CMS on health IT incentive programs. Prior to her ONC role, Jodi was a key drafter of the original HIPAA Privacy and Enforcement Rules and served as HHS’s first senior counsel for health IT. Jodi received a BA in Economics from Tufts University, an MPH from Johns Hopkins School of Public Health, and a JD from Georgetown University Law Center. She is currently Assistant Professor Adjunct at Yale Medical School and serves on the National Academy of Medicine AI Code of Conduct Steering Committee.

Event Resources

Resources:

“The History of State Preemption and Medical Device Regulation: Lessons for Artificial Intelligence Oversight.” Thomason, C., Bucshon, L., Miller, B.J., & Yagi, B. Health Affairs Scholar. March 3, 2026.

“Toward Responsible AI in Health Insurance Decision-Making.” Mello, M., Trotsyuk, A., Mahamadou, A., & Char, D. HAI. February 10, 2026.

“AI, Health, and Health Care Today and Tomorrow. The JAMA Summit Report on Artificial Intelligence.” Angus, D.C., Khera, R., Lieu, T. et. al. JAMA. October 13, 2025.

“How Different States are Approaching AI.” Dawson, G.S., Desouza, K.C., Denford, J.S & Barda Picavet, M. Brookings. August 18, 2025.

“AI and the Future Primary Care Workforce.” Mogk, J., Coleman, K., Rittenhouse, D.,& Muratore, R. California Health Care Foundation. June, 2025.

“Regulation of Health and Health Care Artificial Intelligence.” Mello, M.M and Cohen, G. JAMA. March 17, 2025.

“Healthcare AI Regulation: Guidelines for Maintaining Public Safety and Innovation.” Coleman, K. Paragon Health Institute. December, 2024.

“Artificial Intelligence and Health Care: A Primer.” National Conference of State Legislatures. August 20, 2024.

“Ethical and Legal Challenges of Artificial Intelligence-Driven Healthcare.” Gerke, S., Minssen, T. & Cohen, G. Artificial Intelligence in Healthcare. 2020.

Experts

Kev Coleman

Research Fellow, Paragon Health Institute

Monica Massaro, MPP

Director, Government Relations and Public Policy, Hooper, Lundy & Bookman, PC

Jared Augenstein, M.A., MPH

Senior Managing Director, Manatt Health

Michelle M. Mello, JD, Ph.D., MPhil

Professor of Law, Stanford Law School; Professor of Health Policy, Department of Health Policy, Stanford University School of Medicine; Chair, Healthcare AI Policy Steering Committee, Stanford University Human Centered Artificial Intelligence (HAI)

Christina Silcox, Ph.D

Research Director for Digital Health, Duke-Margolis Institute for Health Policy

Adam C. Solander

Partner, Data, Privacy, and Security, King and Spalding

I. Glenn Cohen, JD

James A. Attwood and Leslie Williams Professor of Law, Deputy Dean & Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics, Harvard Law School

Julia Harris, MPH, MA

Senior Director, Policy, Peterson Center on Healthcare

Sherri Rose, PhD

Professor of Health Policy & Computer Science, Stanford University

Back to All Events